If so, reach out to [email protected]
GLP-1, or Glucagon-Like Peptide-1, has gained attention in recent years for its role in weight management and insulin sensitivity, making it a valuable tool in managing PCOS symptoms
As a GLP-1 receptor agonist, semaglutide is typically well-tolerated and offers a reliable option to help patients reduce appetite, lower calorie intake, and achieve gradual, sustainable weight loss
Adverse events Major hypoglycemia (Table S2) was reported in only 2 patients receiving GLP-1 analogues (liraglutide 1.2 mg QD)
Whilst occasional hot flushes may not require immediate medical attention, certain situations warrant prompt consultation with your GP or diabetes care team: Seek medical advice if you experience: Severe or persistent hot flushes that significantly interfere with daily activities, work, or sleep quality Hot flushes accompanied by other concerning symptoms such as chest pain, palpitations, severe headache, visual disturbances, or difficulty breathing Signs of hypoglycaemia including trembling, confusion, excessive sweating, dizziness, or feeling faintcheck your blood glucose immediately if possible Symptoms of dehydration such as dark urine, extreme thirst, or reduced urination, particularly if you're also experiencing nausea or vomiting Unexplained fever or hot flushes accompanied by chills, which could indicate infection New or worsening symptoms after starting Ozempic or increasing the dose Contact your healthcare provider for routine review if: Hot flushes persist beyond the initial adjustment period (typically 48 weeks) You're uncertain whether symptoms are related to Ozempic, menopause, or another condition You're considering stopping or changing your medication due to side effects You require guidance on managing symptoms or adjusting your diabetes management plan Seek emergency medical attention (call 999 or attend A&E) if you experience: Severe allergic reaction symptoms including facial swelling, difficulty breathing, or widespread rash Severe, persistent abdominal pain, with or without vomiting, which could indicate pancreatitis (a rare but serious side effect of GLP-1 agonists)
